[Press Release] Korea MFDS and U.S. FDA Lead Global Discussion on Advancing
- Registration Date 2024-02-21
- Hit 17209
The Republic of Korea’s Ministry of Food and Drug Safety (Korea MFDS) and the U.S. Food
and Drug Administration (U.S. FDA) will jointly convene a four-day global symposium 「AI
Regulatory and International Symposium」 (AIRIS 2024) assembling regulators and
industry/academia experts from around the world from Feb. 26 to 29, 2024 at the Shilla Seoul
(Seoul, Republic of Korea) under the theme of ‘Use of AI in Medical Product Development’.
Division Office for Global Policy and Strategy
Written by Hyeokseung Kwon
Telephone 043-719-1352